Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer

doi:10.3748/wjg.v11.i14.2188

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2998)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

240

HTML

2372

Figures (1-2)

183

Tables (1-5)

203

Sum=2998

Apr 14, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Apr 14, 2005; 11(14): 2188-2192
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2188

Full Size Figure Download Figure

Figure 1 Immunohistochemistry SP staining and HE staining A: Heparanase-positive (nucleolus, cytoplasm, amphithecium) SP×400 B: bFGF-heparanase-positive (cytoplasm, amphithecium) SP×400 C: MVD as evaluated by immunohistochemistry with CD34 (SPx200) D: HE staining of EC SP×400.

Citation: Han B, Liu J, Ma MJ, Zhao L. Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer. World J Gastroenterol 2005; 11(14): 2188-2192
URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2188.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2188